The 15th Annual International Conference of the

D&CVD Study Group

Endorsed by the EASD
Dan Tel Aviv Hotel, Israel

 

10-12 May 2023

Diabetes & Cardiovascular Disease

Register
Abstracts
Register
Abstracts

Conference Program

08:00
Registration
08:50-09:10
Epigenetic changes, oxidative stress and CV damage in Diabetes
Prof. Francesco Cosentino

Karolinska Institute & Karolinska University Hospital, Stockholm, Sweden
09:10-09:30
How glucose lowering treatments interfere with the autonomic nervous system
Prof. Paul Valensi

Paris-Nord University, France
09:30-09:50
Glucose lowering drugs with positive and negative impact on heart failure or "HFpEF": Role of the diabetologist tackling a multidisciplinary problem
Prof. Eberhard Standl

Forschergruppe Diabetes eV. at Munich Helmholtz Centre, Germany
09:50-10:10
Diabetes and Lipids: Current drug therapy and future perspectives
Prof. Niki Katsiki

International Hellenic University, Greece
10:10-10:30
CVD Risk factors in the CVOTs
Prof. Antonio Ceriello

IRCCS MultiMedica, Milan, Italy
11:20-11:40
GLP1RA based treatments and cardiovascular effects – are all the same?
Prof. Michael Nauck

Ruhr-University, Bochum, Germany
11:40-12:00
SGLT2 Inb. based treatments and cardiorenal effects – are all the same? ( Pre-Recorded)
Prof. Hiddo L. Heerspink

University Medical Center Groningen, Netherlands
12:00-12:30
Pro/Con Debate: The rule of Metformin in Diabetes treatment – is it still essential?
Dr. Mahmoud Ibrahim

EDC Center for Diabetes Education, USA
Prof. Itamar Raz

Diabetes Medical Center, Israel
Show Summary
12:30-12:40
Discussion
13:50-14:10
New horizon about glycemic management and CVD: GLP-1 + GIP, GLP-1 + Glucagon, GLP-1+ GIP + Glucagon, GLP1+ Amylin
Prof. Francesco Giorgino

University of Bari Aldo Moro, Bari, Italy
14:10-14:30
New ESC Guidelines and 2022 ADA Consensus for the diagnosis and treatment of heart failure- key points
Prof. Oliver Schnell

Forschergruppe Diabetes eV. at Munich Helmholtz Centre, Germany
14:30-14:50
New treatment approaches for CKD with a cardiovascular benefit-Key points
Prof. Christoph Wanner

University Hospital of Würzburg, Germany
14:50-15:10
The fatty Liver – a game changer in D& CVD?
Prof. Nebojsa Lalic

University of Belgrade, Serbia
15:10-15:30
The Cardio-Renal Metabolic Concept
Prof. Yehuda Handelsmann

Metabolic Institute of America, USA
15:30-16:30
The cardio – renal- metabolic approach – from Theory to practice: a case study presentation with a panel discussion
Dr. Baruch Itzhak

Clalit Health Services and Technion Faculty of Medicine, Israel
Prof. Per-Henrik Groop

University of Helsinki & Helsinki University Hospital, Finland
Prof. Francesco Cosentino

Karolinska Institute & Karolinska University Hospital, Stockholm, Sweden
Prof. Doina Catrinoiu

“Ovidius” University, Constanta, Romania
Show Summary
08:00
Registration
09:00-09:20
Long acting Insulin preparations – getting better
Prof. Jan Škrha

Charles University in Prague, Czech Republic
09:20-09:40
FRC (Fixed Ratio Combination) Insulin preparations – getting better
Dr. Dario Rahelic

Merkur University Hospital, Zagreb, Croatia
09:40-10:00
GLP1 RA based treatments –getting better
Dr. Roy Eldor

Tel Aviv Sourasky Medical Center, Israel
10:00-10:10
Discussion
11:00-11:20
Leveraging technology for better care of older people with Diabetes
Prof. Tali Cukierman-Yaffe

Sheba Medical Center, Israel
11:20-11:40
Glucose Management Indicator (GMI) and HA1C in T1DM & T2DM – equal or different? The recent evidence
Prof. Tadej Battelino

UMC - University Children's Hospital Ljubljana, Slovenia
11:40-12:00
Artificial intelligence based decision support systems
Prof. Moshe Phillip

Schneider Children's Medical Center, Petah Tikva, Israel
12:00-12:20
Automated insulin delivery systems – where do we go?
Dr. Eytan Roitman

Clalit Health Care Services, Israel
13:20-13:30
General Assembly, Closing Remarks and Announcement of the Next Annual Meeting
Prof. Antonio Ceriello

IRCCS MultiMedica, Milan, Italy
Dr. Baruch Itzhak

Clalit Health Services and Technion Faculty of Medicine, Israel